CTRI/2024/05/067907
Not yet recruiting
未知
Determining the prevalence and molecular epidemiology of respiratory syncytial virus (RSV) in pediatric population at KMC, Manipal, Karnataka - NI
Manipal Institute of Virology, Manipal Academy of Higher Education0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: J210- Acute bronchiolitis due to respiratory syncytial virus
- Sponsor
- Manipal Institute of Virology, Manipal Academy of Higher Education
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptomatic children below 5 years with an acute respiratory infection (ARI), severe acute respiratory infection (SARI), or lower respiratory infection (LRTI), admitted to the pediatric department at Kasturba Hospital.
Exclusion Criteria
- •Patients above 5 years of age and patients with non\-consenting parents or guardians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Gastric Cancer RegistryNeoplasmsKCT0002284Kyungpook National University Medical Center18,000
Recruiting
Not Applicable
Molecular pathological epidemiology research on pancreatic tumorsPancreatic tumorsJPRN-UMIN000044027Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo2,000
Recruiting
Not Applicable
Epidemiological Study to Determine the Prevalence of ctDNA Positivity in Participants With Stage II (High Risk) or Stage III CRC After Surgery With Curative (R0) Intent and Subsequent Adjuvant Chemotherapy With Monitoring of ctDNA During Clinical Follow-upColorectal Cancer Stage IIColorectal Cancer Stage IIIDRKS00025104BioNTech SE1,500
Recruiting
Not Applicable
Epidemiology and clinical characteristics - based Rome III and IV criteria in Japanese FD patients: a multicenter prospective observational studyJPRN-UMIN000041094Hyogo College of Medicine200
Recruiting
Not Applicable
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.Health Condition 1: null- Non Small Cell Lung CancerCTRI/2013/10/004077Roche Products India Pvt Ltd250